{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:16:57Z","timestamp":1762629417277,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["100-2311-B-400-003","101-2311-B-400-002"],"award-info":[{"award-number":["100-2311-B-400-003","101-2311-B-400-002"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-technology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Technology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.slast.2025.100255","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T12:22:13Z","timestamp":1739362933000},"page":"100255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhanced construction of a bivalent adenovirus-based vaccine for preventing childhood pathogens: Human respiratory syncytial virus and norovirus"],"prefix":"10.1016","volume":"31","author":[{"given":"Ying-Chin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-0389","authenticated-orcid":false,"given":"Chia-Chyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-1338","authenticated-orcid":false,"given":"Yen-Hung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.slast.2025.100255_bib0001","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.1014577107","article-title":"Chimpanzees as an animal model for human norovirus infection and vaccine development","volume":"108","author":"Bok","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.slast.2025.100255_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory syncytial virus\u2013a comprehensive review","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.slast.2025.100255_bib0003","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.1203140","article-title":"Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection","volume":"190","author":"Brincks","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.slast.2025.100255_bib0004","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbrc.2005.04.155","article-title":"Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells","volume":"332","author":"Byun","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.slast.2025.100255_bib0005","first-page":"291","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children","volume":"66","author":"Chanock R","year":"1957","journal-title":"Am J Hyg"},{"key":"10.1016\/j.slast.2025.100255_bib0006","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.90.10.4455","article-title":"In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment","volume":"90","author":"Cheng","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.slast.2025.100255_bib0007","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jgv.0.001318","article-title":"Updated classification of norovirus genogroups and genotypes","volume":"100","author":"Chhabra","year":"2019","journal-title":"J Gen Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0008","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jphp.12350","article-title":"Adenoviral vectors as novel vaccines for influenza","volume":"67","author":"Coughlan","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.slast.2025.100255_bib0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.12.2.298","article-title":"Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment","volume":"12","author":"Domachowske","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.slast.2025.100255_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000085367","article-title":"Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome","volume":"72","author":"Ebbert","year":"2005","journal-title":"Respiration"},{"issue":"Suppl 1","key":"10.1016\/j.slast.2025.100255_bib0011","first-page":"77","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"31","author":"Falsey","year":"2005","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.slast.2025.100255_bib0012","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/515286","article-title":"Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization","volume":"177","author":"Gallichan","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.slast.2025.100255_bib0013","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1016\/j.vaccine.2016.10.090","article-title":"Report from the World Health Organization's third product development for vaccines advisory committee (PDVAC) meeting, Geneva, 8-10th June 2016","volume":"37","author":"Giersing","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.slast.2025.100255_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaj1879","article-title":"Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors","volume":"1","author":"Gilman","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.slast.2025.100255_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.slast.2025.100255_bib0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0924-8579(93)90047-9","article-title":"Immunoprophylaxis and immunotherapy: role in the prevention and treatment of repiratory syncytial virus","volume":"2","author":"Groothuis","year":"1993","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.slast.2025.100255_bib0017","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12033-014-9809-2","article-title":"Impact of using different promoters and matrix attachment regions on recombinant protein expression level and stability in stably transfected CHO cells","volume":"57","author":"Ho","year":"2015","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.slast.2025.100255_bib0018","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1523-1755.1999.00369.x","article-title":"Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis","volume":"55","author":"Holdsworth","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.slast.2025.100255_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(63)92239-6","article-title":"The isolation of respiratory syncytial virus from children with acute respiratory disease","volume":"1","author":"Holzel","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.slast.2025.100255_bib0020","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3201\/eid2906.230331","article-title":"Enhanced Adenovirus vaccine safety surveillance in military setting, United States","volume":"29","author":"Iskander","year":"2023","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.slast.2025.100255_bib0021","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.slast.2025.100255_bib0022","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1128\/JVI.01036-09","article-title":"Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus","volume":"83","author":"Kohlmann","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.slast.2025.100255_bib0024","doi-asserted-by":"crossref","first-page":"e30507","DOI":"10.1371\/journal.pone.0030507","article-title":"Human SCARB2-mediated entry and endocytosis of EV71","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.slast.2025.100255_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2016.08.009","article-title":"Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein","volume":"78","author":"Malm","year":"2016","journal-title":"Mol Immunol"},{"key":"10.1016\/j.slast.2025.100255_bib0026","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2015.03.002","article-title":"Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein","volume":"11","author":"McLellan","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0027","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1128\/JVI.01579-10","article-title":"Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F","volume":"84","author":"McLellan","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0028","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.slast.2025.100255_bib0029","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.slast.2025.100255_bib0030","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0031","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendonca","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.slast.2025.100255_bib0032","doi-asserted-by":"crossref","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.slast.2025.100255_bib0033","doi-asserted-by":"crossref","first-page":"e12413","DOI":"10.1371\/journal.pone.0012413","article-title":"Quantitative comparison of constitutive promoters in human ES cells","volume":"5","author":"Norrman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.slast.2025.100255_bib0034","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","article-title":"Immune responses and disease enhancement during respiratory syncytial virus infection","volume":"18","author":"Openshaw","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.slast.2025.100255_bib0035","unstructured":"pfizer, (2023) U.S. FDA approves ABRYSVO\u2122, Pfizer's vaccine for the prevention of Respiratory syncytial virus (RSV) in infants through active immunization of pregnant individuals 32-36 weeks of gestational age."},{"key":"10.1016\/j.slast.2025.100255_bib0036","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/aje\/kwq021","article-title":"Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis","volume":"171","author":"Phillips","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.slast.2025.100255_bib0037","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.slast.2025.100255_bib0038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tim.2017.09.009","article-title":"Clinical potential of prefusion RSV F-specific antibodies","volume":"26","author":"Rossey","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.slast.2025.100255_bib0039","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2016.03.011","article-title":"Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture","volume":"130","author":"Shao","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.slast.2025.100255_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.07.004","article-title":"Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses","author":"Shao","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.slast.2025.100255_bib0041","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.4049\/jimmunol.165.6.3136","article-title":"Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo","volume":"165","author":"Smith","year":"2000","journal-title":"Journal of immunology"},{"key":"10.1016\/j.slast.2025.100255_bib0042","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/JVI.01536-14","article-title":"Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease","volume":"89","author":"Su","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0043","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1128\/JVI.01225-14","article-title":"A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes","volume":"88","author":"Swanson","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000983","article-title":"Norovirus gastroenteritis, carbohydrate receptors, and animal models","volume":"6","author":"Tan","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.slast.2025.100255_bib0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tim.2011.05.007","article-title":"Norovirus-host interaction: multi-selections by human histo-blood group antigens","volume":"19","author":"Tan","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.slast.2025.100255_bib0046","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(18)30059-8","article-title":"Molecular surveillance of norovirus, 2005-16: an epidemiological analysis of data collected from the NoroNet network","volume":"18","author":"van Beek","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.slast.2025.100255_bib0047","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/rmv.518","article-title":"Immunopathology of RSV infection: prospects for developing vaccines without this complication","volume":"17","author":"van Drunen Littel-van den Hurk","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.slast.2025.100255_bib0048","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"Van Kampen","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.slast.2025.100255_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003592","article-title":"Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains","volume":"9","author":"Zhu","year":"2013","journal-title":"PLoS Pathog"}],"container-title":["SLAS Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472630325000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472630325000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:13:11Z","timestamp":1762629191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472630325000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"alternative-id":["S2472630325000135"],"URL":"https:\/\/doi.org\/10.1016\/j.slast.2025.100255","relation":{},"ISSN":["2472-6303"],"issn-type":[{"type":"print","value":"2472-6303"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced construction of a bivalent adenovirus-based vaccine for preventing childhood pathogens: Human respiratory syncytial virus and norovirus","name":"articletitle","label":"Article Title"},{"value":"SLAS Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slast.2025.100255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100255"}}